89 related articles for article (PubMed ID: 20732753)
21. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
22. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
[TBL] [Abstract][Full Text] [Related]
23. Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome.
Moore HG; Shia J; Klimstra DS; Ruo L; Mazumdar M; Schwartz GK; Minsky BD; Saltz L; Guillem JG
Ann Surg Oncol; 2004 Nov; 11(11):955-61. PubMed ID: 15525823
[TBL] [Abstract][Full Text] [Related]
24. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.
Diez M; Medrano M; Mugüerza JM; Ramos P; Hernandez P; Villeta R; Martín A; Noguerales F; Ruiz A; Granell J
Anticancer Res; 2000; 20(5C):3907-12. PubMed ID: 11268475
[TBL] [Abstract][Full Text] [Related]
25. Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy.
Saigusa S; Toiyama Y; Tanaka K; Yokoe T; Okugawa Y; Fujikawa H; Matsusita K; Kawamura M; Inoue Y; Miki C; Kusunoki M
Int J Oncol; 2011 Mar; 38(3):655-63. PubMed ID: 21240461
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors in prostate cancer.
Stattin P
Scand J Urol Nephrol Suppl; 1997; 185():1-46. PubMed ID: 9249905
[TBL] [Abstract][Full Text] [Related]
27. Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis.
McCabe A; Dolled-Filhart M; Camp RL; Rimm DL
J Natl Cancer Inst; 2005 Dec; 97(24):1808-15. PubMed ID: 16368942
[TBL] [Abstract][Full Text] [Related]
28. Photodynamic therapy resistant human colon carcinoma HT29 cells show cross-resistance to UVA but not UVC light.
Zacal N; Rainbow AJ
Photochem Photobiol; 2007; 83(3):730-7. PubMed ID: 17576382
[TBL] [Abstract][Full Text] [Related]
29. Multidrug resistance-associated protein 3 confers resistance to chemoradiotherapy for rectal cancer by regulating reactive oxygen species and caspase-3-dependent apoptotic pathway.
Yu Z; Zhang C; Wang H; Xing J; Gong H; Yu E; Zhang W; Zhang X; Cao G; Fu C
Cancer Lett; 2014 Oct; 353(2):182-93. PubMed ID: 25088576
[TBL] [Abstract][Full Text] [Related]
30. Effective Killing of Cancer Cells Through ROS-Mediated Mechanisms by AMRI-59 Targeting Peroxiredoxin I.
Yang YJ; Baek JY; Goo J; Shin Y; Park JK; Jang JY; Wang SB; Jeong W; Lee HJ; Um HD; Lee SK; Choi Y; Rhee SG; Chang TS
Antioxid Redox Signal; 2016 Mar; 24(8):453-69. PubMed ID: 26528922
[TBL] [Abstract][Full Text] [Related]
31. [Preliminary study on relationship between multi-drug resistance-associated protein 4 and radiosensitivity of rectal cancer].
Chai R; Yu ZQ; Fu CG; Wang H; Zhang W; Liu LJ; Zhang C
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):627-30. PubMed ID: 21866459
[TBL] [Abstract][Full Text] [Related]
32. [Clinical pathologic factors predicting tumor response after preoperative neoadjuvant therapy for rectal cancer].
Wu WM; Qiu HZ; Wu B; Xiao Y; Lin GL; Zhou L
Zhonghua Wai Ke Za Zhi; 2010 Mar; 48(5):348-52. PubMed ID: 20450606
[TBL] [Abstract][Full Text] [Related]
33. P53 status as a predictive biomarker for patients receiving neoadjuvant radiation-based treatment: a meta-analysis in rectal cancer.
Chen MB; Wu XY; Yu R; Li C; Wang LQ; Shen W; Lu PH
PLoS One; 2012; 7(9):e45388. PubMed ID: 23049793
[TBL] [Abstract][Full Text] [Related]
34. Murine orthotopic model for the assessment of chemoradiotherapeutic interventions in rectal cancer.
Huerta S; Gao X; Saha D
Anticancer Drugs; 2011 Apr; 22(4):371-6. PubMed ID: 21233706
[TBL] [Abstract][Full Text] [Related]
35. Tailoring treatment of rectal adenocarcinoma: immunohistochemistry for predictive biomarkers.
Kapur P
Anticancer Drugs; 2011 Apr; 22(4):362-70. PubMed ID: 21233707
[TBL] [Abstract][Full Text] [Related]
36. Gene methylation in rectal cancer: predictive marker of response to chemoradiotherapy?
Molinari C; Casadio V; Foca F; Zingaretti C; Giannini M; Avanzolini A; Lucci E; Saragoni L; Passardi A; Amadori D; Calistri D; Zoli W
J Cell Physiol; 2013 Dec; 228(12):2343-9. PubMed ID: 23702823
[TBL] [Abstract][Full Text] [Related]
37. Role of DNA methyltransferase 1 in pharyngeal cancer related to treatment resistance.
Chen CC; Chen WC; Wang WH; Lu CH; Lin PY; Lee KD; Chen MF
Head Neck; 2011 Aug; 33(8):1132-43. PubMed ID: 21284050
[TBL] [Abstract][Full Text] [Related]
38. Role of P53 and Bcl-2 in advanced rectal carcinomas treated with adjuvant therapy.
Piperno G; Cosimelli M; Perrone DR; Mancini R; Buglioni S; Novelli F; Sperduti I; Zerbini V; Garufi C; Mottolese M
J Chemother; 2004 Nov; 16 Suppl 5():11-4. PubMed ID: 15675468
[TBL] [Abstract][Full Text] [Related]
39. Using p53-immunostained large specimens to determine the distal intramural spread margin of rectal cancer.
Pan ZZ; Wan DS; Zhang CQ; Shao JY; Li LR; Chen G; Zhou ZW; Wang FL
World J Gastroenterol; 2006 Mar; 12(10):1626-9. PubMed ID: 16570359
[TBL] [Abstract][Full Text] [Related]
40. [Predictive and prognostic factors for the chemoradiotherapy of rectal cancer].
Karasawa K
Nihon Rinsho; 2011 Apr; 69 Suppl 3():509-15. PubMed ID: 22214013
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
